Company Filing History:
2 out of 67 
2 out of 169 
Years Active: 1992-2007
Title: Jan H Van Maarseveen: Innovator in Neurokinin Receptor Antagonism
Introduction
Jan H Van Maarseveen is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target neurokinin receptors. With a total of 4 patents, his work has implications for various therapeutic applications.
Latest Patents
Van Maarseveen's latest patents include a group of unique diazabicyclo alkane derivatives that exhibit neurokinin-NK receptor antagonistic activity. These compounds are represented by a specific general formula, where various substituents can be phenyl, indolyl, or thiophen-3-yl, among others. Additionally, he has developed piperazine oxime derivatives that also demonstrate NK-1 receptor antagonistic activity, showcasing his innovative approach to drug design.
Career Highlights
Throughout his career, Jan H Van Maarseveen has worked with prominent companies such as Solvay Pharmaceuticals and Duphar International Research. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
He has collaborated with notable colleagues, including Hein K A C Coolen and Wouter I Iwema Bakker, contributing to a rich exchange of ideas and advancements in their field.
Conclusion
Jan H Van Maarseveen's contributions to the field of pharmacology through his innovative patents and collaborations highlight his role as a significant inventor in the development of neurokinin receptor antagonists. His work continues to influence therapeutic strategies in medicine.